Notwithstanding, there has been increasing evidence to indicate that hepatokines such as fetuin-A and fetuin-B may influence the prognoses of NAFLD and associated complications [2]. The gene discussed is AHSG; the disease is metabolic dysfunction-associated steatotic liver disease.